1. Home
  2. DLPN vs NRSN Comparison

DLPN vs NRSN Comparison

Compare DLPN & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.19

Market Cap

14.6M

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.33

Market Cap

14.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
NRSN
Founded
1996
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
14.2M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
DLPN
NRSN
Price
$1.19
$0.33
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
8.6K
472.2K
Earning Date
05-15-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
N/A
EPS
N/A
N/A
Revenue
$56,699,389.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.41
$583.67
P/E Ratio
N/A
N/A
Revenue Growth
9.70
N/A
52 Week Low
$1.02
$0.25
52 Week High
$1.88
$1.30

Technical Indicators

Market Signals
Indicator
DLPN
NRSN
Relative Strength Index (RSI) 45.78 37.86
Support Level $1.06 $0.25
Resistance Level $1.20 $0.74
Average True Range (ATR) 0.05 0.06
MACD -0.00 0.01
Stochastic Oscillator 16.60 11.96

Price Performance

Historical Comparison
DLPN
NRSN

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: